| Literature DB >> 24069505 |
Kathrin Pallauf1, Katrin Giller, Patricia Huebbe, Gerald Rimbach.
Abstract
Diet plays an important role in mammalian health and the prevention of chronic diseases such as cardiovascular disease (CVD). Incidence of CVD is low in many parts of Asia (e.g., Japan) and the Mediterranean area (e.g., Italy, Spain, Greece, and Turkey). The Asian and the Mediterranean diets are rich in fruit and vegetables, thereby providing high amounts of plant bioactives including polyphenols, glucosinolates, and antioxidant vitamins. Furthermore, oily fish which is rich in omega-3 fatty acids is an important part of the Asian (e.g., Japanese) and also of the Mediterranean diets. There are specific plant bioactives which predominantly occur in the Mediterranean (e.g., resveratrol from red wine, hydroxytyrosol, and oleuropein from olive oil) and in the Asian diets (e.g., isoflavones from soybean and epigallocatechin gallate from green tea). Interestingly, when compared to calorie restriction which has been repeatedly shown to increase healthspan, these polyphenols activate similar molecular targets such as Sirt1. We suggest that a so-called "MediterrAsian" diet combining sirtuin-activating foods (= sirtfoods) of the Asian as well as Mediterranean diet may be a promising dietary strategy in preventing chronic diseases, thereby ensuring health and healthy ageing. Future (human) studies are needed which take the concept suggested here of the MediterrAsian diet into account.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24069505 PMCID: PMC3771427 DOI: 10.1155/2013/707421
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
FoxO regulation by Sirt1.
| Cell culture | Treatment | Outcome | Reference |
|---|---|---|---|
| HEK 293T | Stress conditions (H2O2) | ↑ Interaction between Sirt1 and FoxO3 | [ |
| MEF Sirt1−/− | Treatment with LY 294002 (PI3K inhibitor): wild type Sirt1−/− | ↑ Acetylation of FoxO3 | |
| HepG2 | Serum starvation => FoxO translocation into the nucleus | ↑ Deacetylation of FoxO1 by Sirt1 | [ |
| HeLa | Sirt1 overexpression | ↓ FoxO3 activity | [ |
| HEK 293T | Inhibition of Sirt1 | ↓ FoxO4 activity | [ |
Bim: Bcl-2 interacting mediator of cell death, proapoptotic protein; H2O2: hydrogen peroxide; HEK-293T: human embryonic kidney 293 cells containing the T antigen from simian virus; HepG2: human liver carcinoma cell line; MEF: mouse embryonic fibroblasts; MnSOD: manganese superoxide dismutase, part of antioxidative defence; p27: cyclin-dependent kinase inhibitor, controls cell cycle progression; PI3K: phosphatidylinositol 3-kinase.
Cellular localization, activity, and biological function of sirtuins 1–7 according to [63].
| Sirtuin | Localization | Activity | Biological function |
|---|---|---|---|
| Sirt1 | Nucleus/cytosol | Deacetylase | Cell survival/metabolism |
| Sirt2 | Cytosol | Deacetylase | Cell cycle |
| Sirt3 | Mitochondria | Deacetylase | Thermogenesis/metabolism |
| Sirt4 | Mitochondria | ADP-ribosyltransferase | Insulin secretion/metabolism |
| Sirt5 | Mitochondria | Deacetylase | Unknown |
| Sirt6 | Nucleus | ADP-ribosyltransferase | DNA repair |
| Sirt7 | Nucleolus | Unknown | rDNA transcription |
ADP: adenosine diphosphate; rDNA: ribosomal desoxyribonucleic acid; Sirt: sirtuin.
Figure 1Sirt1-mediated regulation of metabolism in different tissues according to [92]. In pancreatic β-cells Sirt1 represses the expression of UCP2, thereby increasing insulin secretion, and Sirt 1 also regulates FoxOs, thereby protecting the β-cells against oxidative stress. In the liver Sirt1 regulates gluconeogenesis by activating PGC-1α. In muscle cells Sirt1 activates both PGC-1α and FoxO, thereby influencing mitochondrial biogenesis, respiration, and fatty acid oxidation. ATP: adenosine triphosphate; FoxO: forkhead box protein O; PGC-1α: peroxisome proliferator-activated receptor-γ coactivator 1 alpha; UCP: uncoupling protein 2.
Effects of calorie restriction or starvation on Sirt1 in different tissues in mice and rats.
| Species | Number animals | Caloric restriction | Tissue | Outcome | Reference |
|---|---|---|---|---|---|
| Mice (C57BL6) | 10 | 40% | Muscle, fat | Sirt1 ↑ | [ |
| Mice | 4 | 15% | Brain, liver | No effect on Sirt1 (protein) | [ |
| Mice | — | 24 h starvation | Liver | Sirt1 ↑ | [ |
| Mice | — | 24 h starvation | Brain, heart, muscle, white adipose tissue, and kidney | Sirt1 ↑ | [ |
| Mice | 10 | 30–40% | White adipose tissue | Sirt1 ↑ | [ |
| Mice | — | 40% | White adipose tissue, liver, kidney, and brain | Sirt1 ↑ | [ |
| Rats | — | 40% | Brain, fat, kidney, and liver | Sirt1 ↑ | [ |
Figure 2Sirt4 mediated amino acid metabolism according to [92]. ASSIS: amino acid-stimulated insulin secretion.
Dietary restriction mimetics: mechanisms and side effects.
|
|
Figure 3Important food items and their corresponding constituents in the Mediterranean, Asian, and so-called MediterrAsian diet.
Sirt1-inducing plant bioactives and the “sirtfoods” they are found in.
|
|
*consumed in Japan as “Molokheka”; #edible plant native to Asia; ◊and possibly other phenolic compounds found in olive oil.